Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099

Reference

Title : CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia - Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
Author(s) : Herrmann N , Ismail Z , Collins R , Desmarais P , Goodarzi Z , Henri-Bhargava A , Iaboni A , Kirkham J , Massoud F , Moser A , Silvius J , Watt J , Seitz D
Ref : Alzheimers Dement (N Y) , 8 :e12099 , 2022
Abstract : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
ESTHER : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
PubMedSearch : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
PubMedID: 35128025

Related information

Citations formats

Herrmann N, Ismail Z, Collins R, Desmarais P, Goodarzi Z, Henri-Bhargava A, Iaboni A, Kirkham J, Massoud F, Moser A, Silvius J, Watt J, Seitz D (2022)
CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
Alzheimers Dement (N Y) 8 :e12099

Herrmann N, Ismail Z, Collins R, Desmarais P, Goodarzi Z, Henri-Bhargava A, Iaboni A, Kirkham J, Massoud F, Moser A, Silvius J, Watt J, Seitz D (2022)
Alzheimers Dement (N Y) 8 :e12099